Evidence map›Paper›PMID 32243609›Full record

Trial reportAmerican journal of hematology2020

The benefits of iron supplementation following blood donation vary with baseline iron status.

Alan E Mast, Aniko Szabo, Mars Stone, Ritchard G Cable, Bryan R Spencer, Joseph E Kiss, NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Oral iron and blood donation: cui bono?Blood transfusion = Trasfusione del sangue · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Alan E MastBlood Research Institute, Versiti, Milwaukee, Wisconsin, USA.ORCID 0000-0003-3740-0318
Aniko SzaboDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Mars StoneVitalant Research Institute, San Francisco, California, USA.
Ritchard G CableAmerican Red Cross Scientific Affairs, Farmington, Connecticut, USA.
Bryan R SpencerAmerican Red Cross Scientific Affairs, Dedham, Massachusetts, USA.
Joseph E KissVitalant Northeast Division, Pittsburgh, Pennsylvania, USA.
NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III
American Red Cross · USMedical College of Wisconsin · USPacific Research Institute · USVitalant · US

Funding

NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100003IWHI NIH HHS HHSN268201100001C
6 · The paper itself

Abstract

Whole blood donation rapidly removes approximately 10% of a donor's blood volume and stimulates substantial changes in iron metabolism and erythropoiesis. We sought to identify donors who benefit from iron supplementation, describe the nature of the benefit, and define the time course for recovery from donation. Blood samples were collected over 24 weeks following whole blood donation from 193 participants, with 96 participants randomized to 37.5 mg daily oral iron. Changes in total body, red blood cell (RBC), and storage iron, hepcidin, erythropoietin, and reticulocyte count were modeled using semiparametric curves in a mixed model. and the changes were compared among six groups defined by baseline ferritin (<12; 12-50; ≥50 ng/mL) and iron supplementation. The effect of oral iron on storage and RBC iron recovery was minimal in donors with baseline ferritin ≥50 ng/mL, but sizeable when ferritin was <50 ng/mL. Iron initially absorbed went to RBC and storage iron pools when ferritin was <12 ng/mL but went mostly to RBCs when ferritin was ≥12 ng/mL. Donors with ferritin ≥12 ng/mL had a "ripple" increase in reticulocytes ~100 days after donation indicating physiological responses occur months following donation. Thus, iron supplements markedly enhance recovery from whole blood donation in donors with ferritin <50 ng/mL. However, full recovery from donation requires over 100 days when taking iron. The findings also highlight the value of the study of blood donors for understanding human hemoglobin and iron metabolism and their usefulness for future studies as additional biomarkers are discovered.

Indexed as

Blood DonorsAgedBiomarkersErythropoietinFemaleFerritinsHemoglobinsHepcidinsHumansIronMaleMiddle AgedReticulocyte CountBiomarkersEPO protein, humanErythropoietinFerritinsHAMP protein, humanHemoglobinsHepcidinsIron

Identifiers

PMID32243609
PMCPMC7393577
OpenAlexW3015155200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.